• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环微RNA与有症状患者的冠状动脉钙化水平相关。

Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients.

作者信息

Liu Wei, Ling Shukuan, Sun Weijia, Liu Tong, Li Yuheng, Zhong Guohui, Zhao Dingsheng, Zhang Pengfei, Song Jinping, Jin Xiaoyan, Xu Zi, Song Hailin, Li Qi, Liu Shujuan, Chai Meng, Dai Qinyi, He Yi, Fan Zhanming, Zhou Yu Jie, Li Yingxian

机构信息

Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China.

State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China.

出版信息

Sci Rep. 2015 Nov 5;5:16099. doi: 10.1038/srep16099.

DOI:10.1038/srep16099
PMID:26537670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4633594/
Abstract

The purpose of this study was to find the circulating microRNAs (miRNAs) co-related with the severity of coronary artery calcification (CAC), and testify whether the selected miRNAs could reflect the obstructive coronary artery disease in symptomatic patients. Patients with chest pain and moderated risk for coronary artery disease (CAD) were characterized with coronary artery calcium score (CACS) from cardiac computed tomography (CT). We analyzed plasma miRNA levels of clinical matched 11 CAC (CACS > 100) and 6 non-CAC (CACS = 0) subjects by microarray profile. Microarray analysis identified 34 differentially expressed miRNAs between CAC and non CAC groups. Eight miRNAs (miR-223, miR-3135b, miR-133a-3p, miR-2861, miR-134, miR-191-3p, miR-3679-5p, miR-1229 in CAC patients) were significantly increased in CAC plasma in an independent clinical matched cohort. Four miRNAs (miR-2861, 134, 1229 and 3135b) were correlated with the degree of CAC. Validation test in angiographic cohort showed that miR-134, miR-3135b and miR-2861 were significantly changed in patients with obstructive CAD . We identified three significantly upregulated circulating miRNAs (miR-134, miR-3135b and 2861) correlated with CAC while detected obstructive coronary disease in symptomatic patients.

摘要

本研究的目的是寻找与冠状动脉钙化(CAC)严重程度相关的循环微RNA(miRNA),并验证所选的miRNA是否能反映有症状患者的阻塞性冠状动脉疾病。对有胸痛且患冠状动脉疾病(CAD)风险中等的患者进行心脏计算机断层扫描(CT)以测定冠状动脉钙评分(CACS)。我们通过微阵列分析临床匹配的11例CAC(CACS>100)和6例非CAC(CACS = 0)受试者的血浆miRNA水平。微阵列分析确定了CAC组和非CAC组之间34种差异表达的miRNA。在独立的临床匹配队列中,8种miRNA(CAC患者中的miR-223、miR-3135b、miR-133a-3p、miR-2861、miR-134、miR-191-3p、miR-3679-5p、miR-1229)在CAC血浆中显著增加。4种miRNA(miR-2861、134、1229和3135b)与CAC程度相关。血管造影队列中的验证试验表明,在阻塞性CAD患者中miR-134、miR-3135b和miR-2861有显著变化。我们鉴定出三种显著上调的循环miRNA(miR-134、miR-3135b和2861)与CAC相关,同时在有症状患者中检测到阻塞性冠状动脉疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/02000962c93c/srep16099-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/2adaa9455377/srep16099-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/13d42ca46c10/srep16099-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/343199603661/srep16099-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/6e9484b22c52/srep16099-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/ea8512eee5ce/srep16099-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/02000962c93c/srep16099-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/2adaa9455377/srep16099-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/13d42ca46c10/srep16099-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/343199603661/srep16099-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/6e9484b22c52/srep16099-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/ea8512eee5ce/srep16099-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b705/4633594/02000962c93c/srep16099-f6.jpg

相似文献

1
Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients.循环微RNA与有症状患者的冠状动脉钙化水平相关。
Sci Rep. 2015 Nov 5;5:16099. doi: 10.1038/srep16099.
2
Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease.翻译家族性高胆固醇血症和冠状动脉疾病患者中源自人冠状动脉平滑肌细胞的微泡的微小RNA特征。
J Mol Cell Cardiol. 2017 May;106:55-67. doi: 10.1016/j.yjmcc.2017.03.005. Epub 2017 Mar 23.
3
Association of Plasma MiRNA-204 and the Presence and Severity of Coronary Artery Calcification in Patients With Type 2 Diabetes.血浆 miRNA-204 与 2 型糖尿病患者冠状动脉钙化的存在及严重程度的相关性。
Angiology. 2021 May;72(5):451-458. doi: 10.1177/0003319720984592. Epub 2021 Jan 5.
4
Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography.通过电子束计算机断层扫描评估,基质Gla蛋白与冠状动脉钙化有关。
Thromb Haemost. 2004 Apr;91(4):790-4. doi: 10.1160/TH03-08-0572.
5
Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.循环微小RNA作为极早发(≤40岁)冠状动脉疾病的新型诊断生物标志物
Biomed Environ Sci. 2016 Aug;29(8):545-554. doi: 10.3967/bes2016.073.
6
Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.循环微RNA作为扩张型心肌病的新型生物标志物
Cardiol J. 2017;24(1):65-73. doi: 10.5603/CJ.a2016.0097. Epub 2016 Oct 17.
7
Coronary artery calcifications in renal graft recipients at the time of transplantation.肾移植受者移植时的冠状动脉钙化
Med Sci Monit. 2007 May;13 Suppl 1:83-9.
8
MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.循环微泡中的微小RNA表达可预测冠心病患者的心血管事件。
J Am Heart Assoc. 2014 Oct 27;3(6):e001249. doi: 10.1161/JAHA.114.001249.
9
Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.微粒诱导的凝血与严重主动脉瓣狭窄中的冠状动脉粥样硬化有关。
PLoS One. 2016 Mar 24;11(3):e0151499. doi: 10.1371/journal.pone.0151499. eCollection 2016.
10
Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.冠心病患者中循环中Toll样受体4反应性微小RNA谱:肾素-血管紧张素系统阻滞剂治疗的前瞻性随机研究结果
Clin Sci (Lond). 2015 Apr;128(8):483-91. doi: 10.1042/CS20140417.

引用本文的文献

1
transcriptomic profiling of indigenous Gaddi vis-à-vis exotic Labrador dogs: insights from systems biology.本地加迪犬与外来拉布拉多犬的转录组分析:系统生物学的见解
Front Vet Sci. 2025 Jun 20;12:1489905. doi: 10.3389/fvets.2025.1489905. eCollection 2025.
2
MicroRNA Signature in an In Vitro Keratinocyte Model of Diabetic Wound Healing.糖尿病创面愈合体外角质形成细胞模型中的 microRNA 特征。
Int J Mol Sci. 2024 Sep 20;25(18):10125. doi: 10.3390/ijms251810125.
3
MicroRNAs and Cardiovascular Disease Risk.微小RNA与心血管疾病风险

本文引用的文献

1
Coronary artery disease: Predicting the progression of coronary artery calcification.冠状动脉疾病:预测冠状动脉钙化的进展
Nat Rev Cardiol. 2014 Oct;11(10):557. doi: 10.1038/nrcardio.2014.117. Epub 2014 Aug 12.
2
Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study.冠状动脉钙化的进展似乎不可避免,但可预测——海因茨·尼克斯多夫召回(HNR)研究结果。
Eur Heart J. 2014 Nov 7;35(42):2960-71. doi: 10.1093/eurheartj/ehu288. Epub 2014 Jul 25.
3
Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials.
Curr Cardiol Rep. 2024 Feb;26(2):51-60. doi: 10.1007/s11886-023-02014-1. Epub 2024 Jan 11.
4
Evaluation of Expression Level of miR-3135b-5p in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity.对经历化疗诱导心脏毒性的乳腺癌患者血液样本中miR-3135b-5p表达水平的评估。
Indian J Clin Biochem. 2023 Oct;38(4):536-540. doi: 10.1007/s12291-022-01075-3. Epub 2022 Sep 6.
5
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.临床生物标志物时代乳腺癌女性全身治疗所致心脏毒性潜在预测指标的新见解:一项系统评价
Cancers (Basel). 2023 Jun 22;15(13):3290. doi: 10.3390/cancers15133290.
6
Differential Expression of microRNAs in Serum of Patients with Chronic Painful Polyneuropathy and Healthy Age-Matched Controls.慢性疼痛性多发性神经病患者与年龄匹配的健康对照者血清中微小RNA的差异表达
Biomedicines. 2023 Mar 2;11(3):764. doi: 10.3390/biomedicines11030764.
7
Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.心血管疾病相关 microRNAs 作为无其他妊娠相关并发症的妊娠期糖尿病第一孕期筛查的新型生物标志物。
Int J Mol Sci. 2022 Sep 13;23(18):10635. doi: 10.3390/ijms231810635.
8
Analysis of miRNA Associated with Coronary Artery Calcification.冠状动脉钙化相关 miRNA 分析。
Comput Math Methods Med. 2022 Jul 25;2022:3708547. doi: 10.1155/2022/3708547. eCollection 2022.
9
Identification of a circulating microRNAs biomarker panel for non-invasive diagnosis of coronary artery disease: case-control study.循环 microRNAs 生物标志物panel 用于非侵入性诊断冠心病的鉴定:病例对照研究。
BMC Cardiovasc Disord. 2022 Jun 24;22(1):286. doi: 10.1186/s12872-022-02711-9.
10
hsa-miR-518-5p/hsa-miR-3135b Regulates the REL/SOD2 Pathway in Ischemic Cerebral Infarction.人源微小RNA-518-5p/人源微小RNA-3135b调控缺血性脑梗死中的REL/超氧化物歧化酶2通路
Front Neurol. 2022 Apr 11;13:852013. doi: 10.3389/fneur.2022.852013. eCollection 2022.
经皮冠状动脉介入治疗的阻塞性冠状动脉疾病患者冠状动脉钙化的预后意义:7项当代支架试验的患者水平汇总分析
Heart. 2014 Aug;100(15):1158-64. doi: 10.1136/heartjnl-2013-305180. Epub 2014 May 20.
4
Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction.循环miR-328和miR-134对急性心肌梗死的预测价值。
Mol Cell Biochem. 2014 Sep;394(1-2):137-44. doi: 10.1007/s11010-014-2089-0. Epub 2014 May 16.
5
Metabolically-healthy obesity and coronary artery calcification.代谢健康型肥胖与冠状动脉钙化。
J Am Coll Cardiol. 2014 Jun 24;63(24):2679-86. doi: 10.1016/j.jacc.2014.03.042. Epub 2014 Apr 30.
6
Circulating exosomal microRNAs as biomarkers of colon cancer.循环外泌体微小RNA作为结肠癌的生物标志物
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
7
Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.全基因组筛查表明,在肝细胞癌中,miR-134通过靶向整合素β1发挥转移抑制作用。
PLoS One. 2014 Feb 3;9(2):e87665. doi: 10.1371/journal.pone.0087665. eCollection 2014.
8
Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.用于检测轻度认知障碍的血浆微小RNA生物标志物:生物标志物验证研究
Aging (Albany NY). 2013 Dec;5(12):925-38. doi: 10.18632/aging.100624.
9
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.循环 miR-29a 是肥厚型心肌病患者心肌肥厚和纤维化的唯一生物标志物,其他上调的 microRNAs 也是如此。
J Am Coll Cardiol. 2014 Mar 11;63(9):920-7. doi: 10.1016/j.jacc.2013.09.041. Epub 2013 Oct 23.
10
Circulating microRNAs as novel biomarkers for diabetes mellitus.循环 microRNAs 作为糖尿病的新型生物标志物。
Nat Rev Endocrinol. 2013 Sep;9(9):513-21. doi: 10.1038/nrendo.2013.86. Epub 2013 Apr 30.